[1] Okamoto T, Suzuki T, Kusakabe S, Tokunaga M, Hirano J, Miyata Y, Matsuura Y. Regulation of Apoptosis during Flavivirus Infection. Viruses. 2017 Aug 28;9(9):243. doi: 10.3390/v9090243.
[2] Turtle L, Solomon T. Japanese encephalitis - the prospects for new treatments. Nat Rev Neurol. 2018 Apr 26;14(5):298-313.
[3] Keng LT, Chang LY. Japanese encephalitis. CMAJ. 2018 May 28;190(21):E657. doi: 10.1503/cmaj.171341.
[4] Wang G, Li H, Yang X, Guo T, Wang L, Zhao Z, Sun H, Hou X, Ding X, Dou C, Ma Q, Yang X, Wang Y, Wang Z, Wang L, Liu J, Wang Z, Wang H, Xie P. Guillain-Barré Syndrome Associated with JEV Infection. N Engl J Med. 2020 Sep 17;383(12):1188-1190. doi: 10.1056/NEJMc1916977.
[5] Yanbing D, Lixia H, Jun C, Song H, Fahu Y, Jinwen T. Corilagin Attenuates the Parkinsonismin Japanese Encephalitis Virus Induced Parkinsonism. Transl Neurosci. 2018 Jul 18;9:13-16. doi: 10.1515/tnsci-2018-0003.
[6] Saher G, Brügger B, Lappe-Siefke C, Möbius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA. High cholesterol level is essential for myelin membrane growth. Nat Neurosci. 2005 Apr;8(4):468-75. doi: 10.1038/nn1426. Epub 2005 Mar 27.
[7] Posor Y, Haucke V. A Golgi-associated lipid kinase controls peripheral nerve myelination. Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):30873-30875. doi: 10.1073/pnas.2021130117. Epub 2020 Nov 13.
[8] Rivera-Correa J, de Siqueira IC, Mota S, do Rosário MS, Pereira de Jesus PA, Alcantara LCJ, Ernst JD, Rodriguez A. Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil. PLoS Negl Trop Dis. 2019 Sep 17;13(9):e0007695. doi: 10.1371/journal.pntd.0007695.
[9] Tobias F, Pathmasiri KC, Cologna SM. Mass spectrometry imaging reveals ganglioside and ceramide localization patterns during cerebellar degeneration in the Npc1-/- mouse model. Anal Bioanal Chem. 2019 Sep;411(22):5659-5668. doi: 10.1007/s00216-019-01989-7. Epub 2019 Jun 29.
[10] Sabatini M, Rolland G, Léonce S, Thomas M, Lesur C, Pérez V, de Nanteuil G, Bonnet J. Effects of ceramide on apoptosis, proteoglycan degradation, and matrix metalloproteinase expression in rabbit articular cartilage. Biochem Biophys Res Commun. 2000 Jan 7;267(1):438-44. doi: 10.1006/bbrc.1999.1983.
[11] Bauer J, Liebisch G, Hofmann C, Huy C, Schmitz G, Obermeier F, Bock J. Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression. PLoS One. 2009 Sep 29;4(9):e7197. doi: 10.1371/journal.pone.0007197.
[12] Pierson TC, Diamond MS. The continued threat of emerging flaviviruses. Nat Microbiol. 2020 Jun;5(6):796-812. doi: 10.1038/s41564-020-0714-0. Epub 2020 May 4.
[13] Katz I, Gilburd B, Shovman O. Zika autoimmunity and Guillain-Barré syndrome. Curr Opin Rheumatol. 2019 Sep;31(5):484-487. doi: 10.1097/BOR.0000000000000629.
[14] Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawché F. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016 Apr 9;387(10027):1531-1539. doi: 10.1016/S0140-6736(16)00562-6. Epub 2016 Mar 2.
[15] Rodríguez Y, Rojas M, Pacheco Y, Acosta-Ampudia Y, Ramírez-Santana C, Monsalve DM, Gershwin ME, Anaya JM. Guillain-Barré syndrome, transverse myelitis and infectious diseases. Cell Mol Immunol. 2018 Jun;15(6):547-562. doi: 10.1038/cmi.2017.142. Epub 2018 Jan 29.
[16] Sejvar JJ, Leis AA, Stokic DS, Van Gerpen JA, Marfin AA, Webb R, Haddad MB, Tierney BC, Slavinski SA, Polk JL, Dostrow V, Winkelmann M, Petersen LR. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis. 2003 Jul;9(7):788-93. doi: 10.3201/eid0907.030129.
[17] Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020 Jun 25;382(26):2574-2576. doi: 10.1056/NEJMc2009191. Epub 2020 Apr 17.
[18] Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019 Nov;15(11):671-683. doi: 10.1038/s41582-019-0250-9. Epub 2019 Sep 20.
[19] Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016 Aug 13;388(10045):717-27. doi: 10.1016/S0140-6736(16)00339-1. Epub 2016 Mar 2.
[20] Fu TL, Ong KC, Tan SH, Wong KT. Japanese Encephalitis Virus Infects the Thalamus Early Followed by Sensory-Associated Cortex and Other Parts of the Central and Peripheral Nervous Systems. J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1160-1170. doi: 10.1093/jnen/nlz103.
[21] Modrak M, Talukder MAH, Gurgenashvili K, Noble M, Elfar JC. Peripheral nerve injury and myelination: Potential therapeutic strategies. J Neurosci Res. 2020 May;98(5):780-795. doi: 10.1002/jnr.24538. Epub 2019 Oct 13.
[22] Farfan-Morales CN, Cordero-Rivera CD, Reyes-Ruiz JM, Hurtado-Monzón AM, Osuna-Ramos JF, González-González AM, De Jesús-González LA, Palacios-Rápalo SN, Del Ángel RM. Anti-flavivirus Properties of Lipid-Lowering Drugs. Front Physiol. 2021 Oct 7;12:749770. doi: 10.3389/fphys.2021.749770.
[23] Li M, Yang J, Ye C, Bian P, Yang X, Zhang H, Luo C, Xue Z, Lei Y, Lian J. Integrated Metabolomics and Transcriptomics Analyses Reveal Metabolic Landscape in Neuronal Cells during JEV Infection. Virol Sin. 2021 Sep 24. doi: 10.1007/s12250-021-00445-0. Epub ahead of print. Erratum in: Virol Sin. 2021 Nov 24.
[24] Yager EJ, Konan KV. Sphingolipids as Potential Therapeutic Targets against Enveloped Human RNA Viruses. Viruses. 2019 Oct 1;11(10):912. doi: 10.3390/v11100912.
[25] Beckmann N, Becker KA. Ceramide and Related Molecules in Viral Infections. Int J Mol Sci. 2021 May 26;22(11):5676. doi: 10.3390/ijms22115676.
[26] Schramm M, Herz J, Haas A, Krönke M, Utermöhlen O. Acid sphingomyelinase is required for efficient phago-lysosomal fusion. Cell Microbiol. 2008 Sep;10(9):1839-53. doi: 10.1111/j.1462-5822.2008.01169.x. Epub 2008 May 13.
[27] Becker KA, Fahsel B, Kemper H, Mayeres J, Li C, Wilker B, Keitsch S, Soddemann M, Sehl C, Kohnen M, Edwards MJ, Grassmé H, Caldwell CC, Seitz A, Fraunholz M, Gulbins E. Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide. Infect Immun. 2017 Dec 19;86(1):e00606-17. doi: 10.1128/IAI.00606-17. PMID: 29084896.
[28] Chung HY, Claus RA. Keep Your Friends Close, but Your Enemies Closer: Role of Acid Sphingomyelinase During Infection and Host Response. Front Med (Lausanne). 2021 Jan 21;7:616500. doi: 10.3389/fmed.2020.616500.
[29] Albeituni S, Stiban J. Roles of Ceramides and Other Sphingolipids in Immune Cell Function and Inflammation. Adv Exp Med Biol. 2019;1161:169-191. doi: 10.1007/978-3-030-21735-8_15.
[30] de Wit NM, den Hoedt S, Martinez-Martinez P, Rozemuller AJ, Mulder MT, de Vries HE. Astrocytic ceramide as possible indicator of neuroinflammation. J Neuroinflammation. 2019 Feb 25;16(1):48. doi: 10.1186/s12974-019-1436-1.
[31] Tani H, Shiokawa M, Kaname Y, Kambara H, Mori Y, Abe T, Moriishi K,Matsuura Y. Involvement of ceramide in the propagation of Japanese encephalitis virus. J Virol. 2010 Mar;84(6):2798-807. doi: 10.1128/JVI.02499-09. Epub 2010 Jan 6.
[32] Kurz J, Parnham MJ, Geisslinger G, Schiffmann S. Ceramides as Novel Disease Biomarkers. Trends Mol Med. 2019 Jan;25(1):20-32. doi: 10.1016/j.molmed.2018.10.009. Epub 2018 Nov 23.
[33] Maceyka M, Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature. 2014 Jun 5;510(7503):58-67. doi: 10.1038/nature13475.
[34] Martín-Acebes MA, Merino-Ramos T, Blázquez AB, Casas J, Escribano-Romero E, Sobrino F, Saiz JC. The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis. J Virol. 2014 Oct;88(20):12041-54. doi: 10.1128/JVI.02061-14. Epub 2014 Aug 13.
[35] Lee JY, Jin HK, Bae JS. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy. BMB Rep. 2020 Jan;53(1):28-34. doi: 10.5483/BMBRep.2020.53.1.278.
[36] Maiuolo J, Gliozzi M, Musolino V, Carresi C, Nucera S, Macrì R, Scicchitano M, Bosco F, Scarano F, Ruga S, Zito MC, Oppedisano F, Mollace R, Paone S, Palma E, Muscoli C, Mollace V. The Role of Endothelial Dysfunction in Peripheral Blood Nerve Barrier: Molecular Mechanisms and Pathophysiological Implications. Int J Mol Sci. 2019 Jun 20;20(12):3022. doi: 10.3390/ijms20123022.
[37] Reinhold AK, Rittner HL. Characteristics of the nerve barrier and the blood dorsal root ganglion barrier in health and disease. Exp Neurol. 2020 May;327:113244. doi: 10.1016/j.expneurol.2020.113244. Epub 2020 Feb 10.
[38] Jernigan PL, Makley AT, Hoehn RS, Edwards MJ, Pritts TA. The role of sphingolipids in endothelial barrier function. Biol Chem. 2015 Jun;396(6-7):681-91. doi: 10.1515/hsz-2014-0305.
[39] Xuan L, Han F, Gong L, Lv Y, Wan Z, Liu H, Ren L, Yang S, Zhang W, Li T, Tan C, Liu L. Ceramide induces MMP-9 expression through JAK2/STAT3 pathway in airway epithelium. Lipids Health Dis. 2020 Aug 24;19(1):196. doi: 10.1186/s12944-020-01373-w.
[40] Stubbs EB Jr. Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies. Exp Neurol. 2020 Sep;331:113385. doi: 10.1016/j.expneurol.2020.113385. Epub 2020 Jun 17.
[41] Zheng B, Wang X, Liu Y, Li Y, Long S, Gu C, Ye J, Xie S, Cao S. Japanese Encephalitis Virus infection induces inflammation of swine testis through RIG-I-NF-ĸB signaling pathway. Vet Microbiol. 2019 Nov;238:108430. doi: 10.1016/j.vetmic.2019.108430. Epub 2019 Sep 28.
[42] Ashraf U, Ding Z, Deng S, Ye J, Cao S, Chen Z. Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage. Virulence. 2021 Dec;12(1):968-980. doi: 10.1080/21505594.2021.1899674.